Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bingley

Showing results (51-60 of 165) with videos related to

Pageof 17
Sort By:
Journal of Immunological Methods|July 18, 2006
Non-specific binding to protein A Sepharose and protein G Sepharose in insulin autoantibody assays may be reduced by pre-treatment with glycine or ethanolamineAlistair J K Williams, Alastair J Norcross, Kyla A Chandler, et al.
The Behavioral and Brain Sciences|August 30, 2023
Why a group-level analysis is essential for effective public policy: The case for a g-frameWilliam J Bingley, S Alexander Haslam, Catherine Haslam, et al.
Diabetologia|February 24, 2001
A comparison of the prevalence of islet autoantibodies in children from two countries with differing incidence of diabetesD Marciulionyte, A J Williams, P J Bingley, et al.
Diabetologia|May 29, 2002
Diabetes in the parents of children with Type I diabetesI F Douek, K M Gillespie, P J Bingley, et al.
Social Science & Medicine (1982)|January 1, 1984
Variability in the management of hypertension and cost-effectiveness: methodology, community care results and potential cost reductionsR D Stevens, L J Bingley, M Boger, et al.
Diabetologia|April 8, 2003
-to: Pani MA, Van Autreve J, Van der Auwera BJ, Gorus FK, Badenhoop K (2002) Non-transmitted maternal HLA DQ2 or DQ8 alleles and risk of Type 1 diabetes in offspring: the importance of foetal or post partum exposure to diabetogenic molecules. Diabetologia 45:1340-1343A P Lambert, K M Gillespie, P J Bingley, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 5, 2002
Eczema and Type 1 diabetesI F Douek, N J Leech, P J Bingley, et al.
Diabetes Technology & Therapeutics|August 17, 2002
Predicting type 1 diabetes using autoantibodies: the latest results from the diabetes autoantibody standardization programPatricia W Mueller, Polly J Bingley, Ezio Bonifacio, et al.
Spinal Cord|December 16, 1998
Pathophysiology of autonomic dysreflexia: long-term treatment with terazosin in adult and paediatric spinal cord injury patients manifesting recurrent dysreflexic episodesS Vaidyanathan, B M Soni, P Sett, et al.
Journal of Autoimmunity|October 31, 1997
A novel micro-assay for insulin autoantibodiesA J Williams, P J Bingley, E Bonifacio, et al.
Pageof 17

Showing results (51-60 of 165) with videos related to

Sort By:
Pageof 17
Journal of Immunological Methods|July 18, 2006
Non-specific binding to protein A Sepharose and protein G Sepharose in insulin autoantibody assays may be reduced by pre-treatment with glycine or ethanolamineAlistair J K Williams, Alastair J Norcross, Kyla A Chandler, et al.
The Behavioral and Brain Sciences|August 30, 2023
Why a group-level analysis is essential for effective public policy: The case for a g-frameWilliam J Bingley, S Alexander Haslam, Catherine Haslam, et al.
Diabetologia|February 24, 2001
A comparison of the prevalence of islet autoantibodies in children from two countries with differing incidence of diabetesD Marciulionyte, A J Williams, P J Bingley, et al.
Diabetologia|May 29, 2002
Diabetes in the parents of children with Type I diabetesI F Douek, K M Gillespie, P J Bingley, et al.
Social Science & Medicine (1982)|January 1, 1984
Variability in the management of hypertension and cost-effectiveness: methodology, community care results and potential cost reductionsR D Stevens, L J Bingley, M Boger, et al.
Diabetologia|April 8, 2003
-to: Pani MA, Van Autreve J, Van der Auwera BJ, Gorus FK, Badenhoop K (2002) Non-transmitted maternal HLA DQ2 or DQ8 alleles and risk of Type 1 diabetes in offspring: the importance of foetal or post partum exposure to diabetogenic molecules. Diabetologia 45:1340-1343A P Lambert, K M Gillespie, P J Bingley, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 5, 2002
Eczema and Type 1 diabetesI F Douek, N J Leech, P J Bingley, et al.
Diabetes Technology & Therapeutics|August 17, 2002
Predicting type 1 diabetes using autoantibodies: the latest results from the diabetes autoantibody standardization programPatricia W Mueller, Polly J Bingley, Ezio Bonifacio, et al.
Spinal Cord|December 16, 1998
Pathophysiology of autonomic dysreflexia: long-term treatment with terazosin in adult and paediatric spinal cord injury patients manifesting recurrent dysreflexic episodesS Vaidyanathan, B M Soni, P Sett, et al.
Journal of Autoimmunity|October 31, 1997
A novel micro-assay for insulin autoantibodiesA J Williams, P J Bingley, E Bonifacio, et al.
Pageof 17